healthblogs.net Blogs

More and more pharmaceutical companies are launching Facebook pages that promote their products. The latest is Allergan, which launched a celebrity Facebook campaign for Juvederm, a dermal filler used for “long-lasting correction of moderate to severe facial wrinkles and folds.”…

In comments to the FDA, Johnson & Johnson (JNJ) stated “Flexibility in regulatory approach is crucial in the evolving digital world.” The comment was part of an 8-page document submitted to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products…

One federal agency suggesting ways that another federal agency might better do its job is commonplace in Washington D.C., but it’s of particular interest for this editor when the topic is mobile health. Within the FCC’s 360 page National Broadband…

This week MobiHealthNews had a chance to discuss wireless health trends and activities at the West Wireless Health Institute with the Institute’s new CEO Don Casey. We asked Casey to list five things the WWHI will accomplish in 2010, to…

Yahoo! submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).

In defense of the “one-click rule” for space-limited “generic” search ads and “Rich Ads in Search (RAIS),” Yahoo!…

Within the healthcare chapter of the FCC’s National Broadband Plan, which the agency published this morning, the FCC recommended that it work together with the FDA to clarify regulatory requirements and the approval processes for converged communications and health care…

FDA is considering issuing new guidelines regarding regulation of pharmaceutical use of the Internet for promoting drugs. The drug industry and online service providers like Google and Yahoo! hammered into the FDA’s head how important the Internet is for health…

“The iPhone has created a new direction for our company,” Mark Cain, CTO, MIMvista said in June 2008. “We have taken a complex desktop application removed it from the realm of black art and placed it in the hands of…

Merck submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).

About 75% of Merck’s comments that specifically address FDA’s questions is devoted to an argument in favor of…

AstraZeneca (AZ) submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).

Again and again throughout its comments to the FDA, AstraZeneca defends the concept that social media conversations…